The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
about
A RING to rule them all? Insights into the Map3k1 PHD motif provide a new mechanistic understanding into the diverse roles of Map3k1Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale.MAP3K1 function is essential for cytoarchitecture of the mouse organ of Corti and survival of auditory hair cells.Myocyte-restricted focal adhesion kinase deletion attenuates pressure overload-induced hypertrophyIntermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.The AP-1 transcription factor c-Jun prevents stress-imposed maladaptive remodeling of the heart.Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy.The role of MEKK1 in hypertrophic cardiomyopathy.Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectivesAblation of phospholamban and sarcolipin results in cardiac hypertrophy and decreased cardiac contractilityc-Jun N-terminal kinase (JNK-1) confers protection against brief but not extended ischemia during acute myocardial infarction.Peroxisome proliferator-activated receptor (PPAR) gene profiling uncovers insulin-like growth factor-1 as a PPARalpha target gene in cardioprotection.MAP3Ks as central regulators of cell fate during development.Telomere attrition and Chk2 activation in human heart failureActivation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy.Phosphoinositide 3-kinase(p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy.Steroidal Saponin Diosgenin from Dioscorea bulbifera Protects Cardiac Cells from Hypoxia-reoxygenation Injury Through Modulation of Pro-survival and Pro-death MoleculesDifferences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure.Novel methods for measuring cardiac autophagy in vivo.Mitogen-activated protein kinases in heart development and diseasesStretch-induced regulation of angiotensinogen gene expression in cardiac myocytes and fibroblasts: opposing roles of JNK1/2 and p38alpha MAP kinasesThe rationale for cardiomyocyte resuscitation in myocardial salvage.Elucidation of thioredoxin target protein networks in mouse.Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway.Cdc42 is an antihypertrophic molecular switch in the mouse heart.Adenylyl cyclase type 5 protein expression during cardiac development and stress.Genetic inhibition of calcineurin induces diastolic dysfunction in mice with chronic pressure overload.Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases.c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling.H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.Endogenous muscle atrophy F-box mediates pressure overload-induced cardiac hypertrophy through regulation of nuclear factor-kappaB.The CRM1 nuclear export receptor controls pathological cardiac gene expression.Phosphorylation of Bad at Thr-201 by JNK1 promotes glycolysis through activation of phosphofructokinase-1.Nix-mediated apoptosis links myocardial fibrosis, cardiac remodeling, and hypertrophy decompensation.Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes.Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.Protein kinase g iα inhibits pressure overload-induced cardiac remodeling and is required for the cardioprotective effect of sildenafil in vivo.Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice.TGF-beta1 improves cardiac performance via up-regulation of laminin receptor 37/67 in adult ventricular cardiomyocytes.MEF2 transcriptional activity maintains mitochondrial adaptation in cardiac pressure overload.
P2860
Q28083145-E6BF3EFB-25B9-4A22-9212-EA7E6541D85CQ28296128-366B8FBA-840B-4707-8B3D-7D5585E7564CQ30391988-1F6C6EA5-CCCE-4A5A-9A49-D1B592E6619EQ30439445-C758A462-E9B7-4B1C-B940-8C77C4D66FFBQ30477341-DBC7CE32-1BAD-408B-A184-334F3F139C81Q31138518-25270A0D-F421-40C5-8E39-F839B54362B7Q34274405-8A73201C-8922-4C54-83AC-D17AE074163FQ34286589-CE9EF4ED-CDD6-4634-8D5D-BF3D4D9B2EBEQ34289211-7E99D4E4-3726-41CA-BC85-14F64DD259D0Q34485808-9E5B3A73-8A1B-4869-851A-7C210E9FEAD8Q34799991-BD073A5C-0039-49F7-9C99-8EF812D76F85Q34800455-D1A9168C-9580-420B-834D-9934309FC7CFQ34853182-DF53A691-5477-400B-A895-20609351DF97Q34983035-5C4B2AC4-5B55-46E2-8619-C3CCFC026081Q34997854-C223BE41-29C2-42AE-995E-B6057CCAC299Q36350066-0FDBB338-56FF-469A-BFAA-2C14C049699FQ36687399-3C5C8C4E-7117-4DE5-A037-76DAB3B984ABQ36745702-8E535015-1939-417C-A658-D7CDD6C74E19Q36858520-044F77BA-E2FD-448E-9DA3-BAB0CB52C300Q36944485-2BE3B041-C7BB-4D43-A41D-AC22EE020304Q37103505-8231BEAC-BBD4-4CAD-9E4F-7C919D974843Q37194572-62CBEE30-F21B-4C41-AA2F-50F5F196CDBCQ37258100-D57A5889-C8E6-413B-8EC2-A2EBB631DA7EQ37296169-9DFA25AE-A565-43BB-BFD6-3AF972E27C2BQ37363031-AC052C7F-2963-4A4C-93EE-8C9EA6F7ECAEQ37430967-514650B1-CC4D-4FD6-98EB-2F097D2BC9D1Q37430992-50B4CD5F-97DF-4F4B-837A-7770BAA0AA84Q38121745-E2C056FC-BCCF-4784-B711-06518015FD94Q39927730-8229C259-C217-4695-AC98-7F039DF8EC8DQ40337583-EED72093-1558-4550-B3CB-569F5E4B0928Q40367733-D3343396-6B73-4494-A123-76E2357DD12BQ40586178-7BAEE33A-499A-4EA2-B049-7C558E38A9A6Q40642702-6DC0891F-1977-4E50-B20A-51A72E3F369DQ41764115-3ADFBAFD-9C58-47FC-AA8C-F646B09533A4Q41829105-1ED2A985-8E59-46DB-B912-A8B0513A1FC2Q41943057-F7CFA799-2161-4EE2-9BD7-CB9A87FEF58EQ42133076-83005AE2-9325-40C6-88E5-8908AF23E92EQ42416763-F5F8E046-B649-439A-AB3F-699CD68989B7Q42473066-90C94A0A-D6CA-4CE1-AE50-C92896EBDCD7Q43214524-6AE34196-7512-4B3A-AAD7-62D39ECC5A6D
P2860
The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@ast
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@en
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@nl
type
label
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@ast
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@en
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@nl
prefLabel
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@ast
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@en
The MEKK1-JNK pathway plays a ...... t mediate cardiac hypertrophy.
@nl
P2093
P2860
P1476
The MEKK1-JNK pathway plays a ...... ot mediate cardiac hypertrophy
@en
P2093
Chull Hong
Dorothy E Vatner
Gary L Johnson
Gen Takagi
Guiping Yang
Jill Warden
Olivier Montagne
Stephen F Vatner
P2860
P304
P356
10.1172/JCI0214938
10.1172/JCI14938
P407
P577
2002-07-01T00:00:00Z